Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly distributes Frist bioterror guide

Executive Summary

Lilly sales reps will distribute 5,000 copies of Sen. Bill Frist's (R-Tenn.) bioterrorism guide, When Every Moment Counts, to physicians. "In the event of a bioterrorism attack, this excellent resource undoubtedly has the potential to save countless lives," CEO Sidney Taurel told a Capitol Hill bioterrorism briefing hosted by the Public Forum Institute April 25. Lilly is one of four manufacturers participating in a pilot program to disseminate anthrax brochures to physicians (1"The Pink Sheet" April 15, p. 5)...

You may also be interested in...



PhRMA Anthrax Brochure Includes Off-Label Information Disclaimer

The Pharmaceutical Research & Manufacturers of America's anthrax educational brochure includes a disclaimer that the information has not been approved by FDA

Faster, Better? Fujitsu, Polarisqb 'Quantum-Inspired' Tech Speeds Discovery

Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.

Keeping Track: Oncology Submissions From Blueprint, Y-mAbs, BMS/bluebird; Approvals For BMS’ Reblozyl, LFB’s SevenFact

The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.

UsernamePublicRestriction

Register

PS039744

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel